Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family.
Navarro-Fernández J, Eugenia de la Morena-Barrio M, Martínez-Alonso E, Dybedal I, Toderici M, Bohdan N, Miñano A, Heimdal K, Abildgaard U, Martínez-Menárguez JÁ, Corral J, Vicente V.
Navarro-Fernández J, et al.
Oncotarget. 2018 Sep 4;9(69):33202-33214. doi: 10.18632/oncotarget.26059. eCollection 2018 Sep 4.
Oncotarget. 2018.
PMID: 30237862
Free PMC article.